Preliminary reports reveal conolidine may perhaps inhibit distinct ion channels, cutting down neuronal excitability and restricting pain signals. This mechanism is especially pertinent in neuropathic pain, where irregular signaling leads to persistent soreness. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to